This site is intended for healthcare professionals only
LoginRegister
AbbVie seeks USFDA nod for combination regimen of Venclexta, AcalabrutinibAstraZeneca-Daiichi Sankyo Datopotamab deruxtecan gets USFDA Breakthrough Therapy Designation for...
Jan Aushadhi KendrasBajaj Healthcare enters into CDMO contract with UK/EU-based companies for 15 new APIs
Child Given Wrong Injection at Government HospitalUSFDA approves commercial production of Vasostrict at Endo newest Indore facility
NPPA Panel Defers Biological Es Pneumonia Vaccine Price Exemption, Seeks ClarificationRevise protocol for conducting Phase I CT in India: CDSCO Panel Tells Biological E on Typhoid and...
positive phase 3 trialCDSCO Waives Local Clinical Trials for Drugs Approved in Select Countries: Health Minister
Alembic Pharma commissions new manufacturing facility in Pithampur to expand business6 step-down subsidiaries of Alembic Pharma dissolves
NGT seeks response from Environment Ministry on Hyderabad pharma unit blastNGT seeks response from Environment Ministry on Hyderabad pharma unit blast
Biocon Biologics Yesafili gets Health Canada nod for eye diseasesBiocon gets EIR with VAI status from USFDA for Bengaluru API facility
Novartis ianalumab Phase III trial meets primary endpoint in immune thrombocytopeniaUS Appeals Court decision favors MSN Pharma in Novartis heart drug Entresto generic dispute
Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun PharmaConduct phase III clinical study on resistant hypertension: CDSCO Panel tells Sun Pharmaceutical...
Zydus Lifesciences Reports Rs 6,573.7 Cr Revenue in Q1 FY26, Net Profit Rises 3%Zydus Lifscience gets CDSCO Panel nod to study Rabies Vaccine
Akums Drugs, Tamil Nadu Agricultural University collaborate for pharmaceutical innovationAkum Drugs & Pharmaceutical gets CDSCO Panel nod for BE study of FDC Eplerenone plus Torsemide...
X